Methylene Chloride

Methylene Chloride

SCHEMBL3209457

COc1cc2c(-c3ccc(Br)cc3)cc3c(c2cc1OC)C=CC(c1ccccc1)(c1ccc(N2CCCC2)cc1)O3.ClCCl

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.39
S1PR1 P21453 1/20 0.35
BACE1 P56817 1/20 0.34
HTR7 P34969 1/20 0.32
DRD2 P14416 5/20 0.32
DRD4 P21917 4/20 0.32
DRD3 P35462 4/20 0.32
KDM4E B2RXH2 3/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 2/20 0.32
KMT2A Q03164 2/20 0.32
TP53 P04637 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
ALOX12 P18054 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylene Chloride SCHEMBL3037402 0.99 ACHE (0.38) ACHES1PR1BACE1HTR7DRD2
SCHEMBL3207524 0.97 ACHE (0.41) ACHES1PR1BACE1HTR7DRD2
SCHEMBL12022729 0.96 ACHE (0.40) ACHES1PR1BACE1HTR7DRD2
SCHEMBL3039685 0.88 ACHE (0.40) ACHES1PR1BACE1HTR7KDM4E
SCHEMBL13219267 0.86 ALDH1A1 (0.33) ACHEKDM4EMEN1ALDH1A1KMT2A
SCHEMBL3037071 0.83 ACHE (0.37) ACHES1PR1BACE1KDM4EMEN1
SCHEMBL14922181 0.83 ACHE (0.36) ACHES1PR1
SCHEMBL3036600 0.83 ACHE (0.36) ACHES1PR1
SCHEMBL13219248 0.83 ACHE (0.36) ACHETP53KCNH2EHMT2
SCHEMBL13219244 0.83 HRH3 (0.37) ACHES1PR1TP53HRH1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436184-B2 6-(biphenyl-ester)-3H-naphtho[2,1-b]pyrans as photochromic dichroic dyes and optical article containing them ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE (FR) 2013-05-07 US disclosed
EP-2066650-B1 3H-NAPHTHO[2,1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM ESSILOR INT (FR) 2011-12-21 EP disclosed
US-20100039688-A1 6-(BIPHENYL-ESTER)-3H-NAPHTHO[2,1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM ESSILOR INTERNATIONAL (FR) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100039688-A1 6-(BIPHENYL-ESTER)-3H-NAPHTHO[2,1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM NR0B1, CBR1, NR0B2 ACHE 2340/4885S1PR1 453/4885BACE1 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.